Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Zinc as a New Adjuvant Therapy for Cow Milk Protein Allergy in Children, A Randomized Controlled Trial

NCT06673082 is registered in ClinicalTrials.gov with Kasr El Aini Hospital as lead sponsor.

NCT NCT06673082
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06673082 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Zinc as a New Adjuvant Therapy for Cow Milk Protein Allergy in Children, A Randomized Controlled Trial
Lead sponsor
Kasr El Aini Hospital
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
December 1, 2024
Completion date
May 15, 2025
Enrollment
190 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cow milk protein allergy